NO910874L - Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.Info
- Publication number
- NO910874L NO910874L NO91910874A NO910874A NO910874L NO 910874 L NO910874 L NO 910874L NO 91910874 A NO91910874 A NO 91910874A NO 910874 A NO910874 A NO 910874A NO 910874 L NO910874 L NO 910874L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- therapeutic active
- piperide
- ingredients
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Diabetes (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9002855A FR2659323B1 (fr) | 1990-03-07 | 1990-03-07 | Derives de 4-(aminomethyl) piperidine, leur preparation et leur application en therapeutique. |
Publications (2)
Publication Number | Publication Date |
---|---|
NO910874D0 NO910874D0 (no) | 1991-03-06 |
NO910874L true NO910874L (no) | 1991-09-09 |
Family
ID=9394458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO91910874A NO910874L (no) | 1990-03-07 | 1991-03-06 | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5179108A (de) |
EP (1) | EP0447292A1 (de) |
JP (1) | JPH04217663A (de) |
KR (1) | KR910016695A (de) |
AU (1) | AU632669B2 (de) |
CA (1) | CA2037610A1 (de) |
FI (1) | FI911133A (de) |
FR (1) | FR2659323B1 (de) |
HU (1) | HUT57723A (de) |
IE (1) | IE910747A1 (de) |
IL (1) | IL97447A0 (de) |
NO (1) | NO910874L (de) |
NZ (1) | NZ237340A (de) |
PT (1) | PT96952A (de) |
ZA (1) | ZA911650B (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681320B1 (fr) * | 1991-09-12 | 1994-01-14 | Synthelabo | Derives de n-(4,7dimethoxyindan-2-yl)-1-(phenylcarbonyl)-n-propyl-piperidine-4-methanamine, leur preparation et leur application en therapeutique. |
FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
FR2701479B1 (fr) * | 1993-02-11 | 1995-05-12 | Pf Medicament | Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique. |
FR2769628B1 (fr) * | 1997-10-09 | 1999-11-12 | Synthelabo | Derives de n-(2,3-dihydro-1h-inden-2-yl)-n-propyl-8- azabicyclo[3.2.1.]octane-3-methanamine, leur preparation et leur application en therapeutique |
UA58476C2 (uk) * | 1997-10-09 | 2003-08-15 | Санофі-Сентелябо | Похідні 8-азабіцикло[3.2.1]октан-3-метанаміну, фармацевтична композиція та лікарський засіб |
US6777554B2 (en) | 2001-02-05 | 2004-08-17 | Teva Pharmaceutical Industries Ltd. | Preparation of N-methylparoxetine and related intermediate compounds |
CA2469055C (en) | 2001-12-03 | 2011-03-29 | F. Hoffmann-La Roche Ag | Aminotetralin derivatives as muscarinic receptor antagonists |
KR100687992B1 (ko) | 2001-12-03 | 2007-02-27 | 에프. 호프만-라 로슈 아게 | 무스카린 수용체 길항제로서 4-피페리딘일 알킬아민 유도체 |
MXPA05000434A (es) * | 2002-07-08 | 2005-04-19 | Ranbaxy Lab Ltd | Derivados de hexano [3.1.0] azabiciclo 3,6-disustituido utiles como antagonistas de receptor muscarinico. |
US7488748B2 (en) * | 2003-01-28 | 2009-02-10 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
EP1618091A1 (de) * | 2003-04-09 | 2006-01-25 | Ranbaxy Laboratories, Ltd. | Substituierte azabicyclohexanderivate als antagonisten von muscarinrezeptoren |
BRPI0409302A (pt) * | 2003-04-11 | 2006-04-11 | Ranbaxy Lab Ltd | derivados azabiciclo como antagonistas de recetores muscarìnicos, método para sua preparação e composição farmacêutica contendo os mesmos |
WO2006054162A1 (en) * | 2004-11-19 | 2006-05-26 | Ranbaxy Laboratories Limited | Azabicyclic muscarinic receptor antagonists |
US20100035954A1 (en) * | 2004-12-15 | 2010-02-11 | Mohammad Salman | Acid addition salts of muscarinic receptor antagonists |
US20080319043A1 (en) * | 2005-05-03 | 2008-12-25 | Mohammad Salman | 3,6-Disubstituted Azabicyclo (3.1.0) Hexane Derivatives as Muscarinic Receptor Antagonists |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1250719A (de) * | 1969-03-19 | 1971-10-20 | ||
FR2484415A1 (fr) * | 1980-06-13 | 1981-12-18 | Pharmindustrie | Nouveaux derives de l'indene, procedes pour leur preparation, et leur utilisation comme medicaments |
US4564628A (en) * | 1983-01-03 | 1986-01-14 | Nelson Research & Development Co. | Substituted 2-aminotetralins |
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
-
1990
- 1990-03-07 FR FR9002855A patent/FR2659323B1/fr not_active Expired - Fee Related
-
1991
- 1991-03-04 EP EP91400585A patent/EP0447292A1/de not_active Withdrawn
- 1991-03-05 IL IL97447A patent/IL97447A0/xx unknown
- 1991-03-06 US US07/665,481 patent/US5179108A/en not_active Expired - Fee Related
- 1991-03-06 KR KR1019910003598A patent/KR910016695A/ko not_active Application Discontinuation
- 1991-03-06 AU AU72670/91A patent/AU632669B2/en not_active Ceased
- 1991-03-06 NZ NZ237340A patent/NZ237340A/xx unknown
- 1991-03-06 NO NO91910874A patent/NO910874L/no unknown
- 1991-03-06 HU HU91731A patent/HUT57723A/hu unknown
- 1991-03-06 ZA ZA911650A patent/ZA911650B/xx unknown
- 1991-03-06 JP JP3067972A patent/JPH04217663A/ja active Pending
- 1991-03-06 IE IE074791A patent/IE910747A1/en unknown
- 1991-03-06 PT PT96952A patent/PT96952A/pt not_active Application Discontinuation
- 1991-03-06 CA CA002037610A patent/CA2037610A1/en not_active Abandoned
- 1991-03-06 FI FI911133A patent/FI911133A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
IL97447A0 (en) | 1992-06-21 |
PT96952A (pt) | 1991-10-31 |
HUT57723A (en) | 1991-12-30 |
EP0447292A1 (de) | 1991-09-18 |
FI911133A (fi) | 1991-09-08 |
FR2659323A1 (fr) | 1991-09-13 |
HU910731D0 (en) | 1991-09-30 |
NZ237340A (en) | 1992-11-25 |
AU632669B2 (en) | 1993-01-07 |
JPH04217663A (ja) | 1992-08-07 |
US5179108A (en) | 1993-01-12 |
FI911133A0 (fi) | 1991-03-06 |
KR910016695A (ko) | 1991-11-05 |
FR2659323B1 (fr) | 1992-06-12 |
CA2037610A1 (en) | 1991-09-08 |
AU7267091A (en) | 1991-09-12 |
IE910747A1 (en) | 1991-09-11 |
ZA911650B (en) | 1991-12-24 |
NO910874D0 (no) | 1991-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO904694D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
NO901684L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
NO912672L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oligomerer. | |
NO884154D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive preparater. | |
NO903088L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater. | |
NO874869D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
NO902411D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. | |
NO883750D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. | |
NO910874L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. | |
NO890155L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. | |
NO900919L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske etere. | |
NO891723L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO914071D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser | |
NO904800D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karbamater. | |
NO894423D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive propanolaminer. | |
NO900972D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
NO892871D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
NO882281D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
NO882282L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
NO883959D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere. | |
NO890724L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. | |
NO904470D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater. | |
NO890519D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater. | |
NO890506D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kloranilin-derivater. |